Volk R J, Cantor S B, Spann S J, Cass A R, Cardenas M P, Warren M M
Department of Family Medicine, University of Texas Medical Branch at Galveston, USA. bvolk%
Arch Fam Med. 1997 Jan-Feb;6(1):72-6. doi: 10.1001/archfami.6.1.72.
The benefits of screening for prostate cancer are uncertain. Outcomes of treatment are particularly important to couples because they challenge the most intimate aspects of a couple's relationship. This study used clinical decision analysis to explore the preferences of 10 couples for prostate cancer screening. The decision-analytic model found that 7 of 10 husbands preferred the no screening strategy, while 9 of 10 wives preferred screening for their husbands. Wives associated little burden with complications of treatment, preferring to maximize their husbands' quantity of life regardless of complications. The issue of who is the decision maker is paramount in the case of prostate cancer screening. Optimal screening strategies may differ for husbands and wives. Guidelines for prostate cancer screening and management should consider assessing preferences on an individual couple basis.
前列腺癌筛查的益处尚不确定。治疗结果对夫妻双方尤为重要，因为它们挑战了夫妻关系中最私密的方面。本研究采用临床决策分析来探究10对夫妻对前列腺癌筛查的偏好。决策分析模型发现，10名丈夫中有7名倾向于不筛查策略，而10名妻子中有9名希望为丈夫进行筛查。妻子们认为治疗并发症带来的负担较小，更愿意不顾并发症来最大化丈夫的生命质量。在前列腺癌筛查的情况下，谁是决策者这一问题至关重要。丈夫和妻子的最佳筛查策略可能不同。前列腺癌筛查和管理指南应考虑在个体夫妻的基础上评估偏好。
